{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:08:40Z","timestamp":1771459720169,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/eurheartj\/ehy480","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T20:23:09Z","timestamp":1532463789000},"page":"1049-1056","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacological therapy in adult congenital heart disease: growing need, yet limited evidence"],"prefix":"10.1093","volume":"40","author":[{"given":"Margarita","family":"Brida","sequence":"first","affiliation":[{"name":"Adult Congenital Heart Centre, Centre for Pulmonary Hypertension, Royal Brompton Hospital, Sydney St, Chelsea London, UK"},{"name":"National Heart and Lung Institute, Imperial College, Kensington London, UK"},{"name":"Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Albert-Schweitzer-Stra\u00dfe 33, M\u00fcnster, Germany"},{"name":"Division of Valvular Heart Disease and Adult Congenital Heart Disease, Department of Cardiovascular Medicine, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard-Paul","family":"Diller","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre, Centre for Pulmonary Hypertension, Royal Brompton Hospital, Sydney St, Chelsea London, UK"},{"name":"National Heart and Lung Institute, Imperial College, Kensington London, UK"},{"name":"Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Albert-Schweitzer-Stra\u00dfe 33, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Nashat","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre, Centre for Pulmonary Hypertension, Royal Brompton Hospital, Sydney St, Chelsea London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Strozzi","sequence":"additional","affiliation":[{"name":"Division of Valvular Heart Disease and Adult Congenital Heart Disease, Department of Cardiovascular Medicine, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Milicic","sequence":"additional","affiliation":[{"name":"Division of Valvular Heart Disease and Adult Congenital Heart Disease, Department of Cardiovascular Medicine, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Albert-Schweitzer-Stra\u00dfe 33, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre, Centre for Pulmonary Hypertension, Royal Brompton Hospital, Sydney St, Chelsea London, UK"},{"name":"National Heart and Lung Institute, Imperial College, Kensington London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ahj.2012.07.023","article-title":"The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation","volume":"164","author":"van der Bom","year":"2012","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B2","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B3","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B4","first-page":"1233","article-title":"Risk factors for excess mortality in adults with congenital heart diseases","volume":"38","author":"Oliver","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIR.0000000000000352","article-title":"Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association","volume":"133","author":"Stout","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/eurheartj\/ehv741","article-title":"Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology","volume":"37","author":"Budts","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/eurheartj\/ehx685","article-title":"Management errors in adults with congenital heart disease: prevalence, sources, and consequences","volume":"39","author":"Cordina","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B10","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: a systematic review and meta-analysis of the literature","volume":"36","author":"Vamos","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2008.04.056","article-title":"Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study","volume":"129","author":"Therrien","year":"2008","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","article-title":"Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial","volume":"127","author":"van der Bom","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B13","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.105.543470","article-title":"Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial","volume":"112","author":"Dore","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.amjcard.2006.10.025","article-title":"Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle","volume":"99","author":"Doughan","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0828-282X(06)70293-8","article-title":"A case series of systemic right ventricular dysfunction post atrial switch for simple D-transposition of the great arteries: the impact of beta-blockade","volume":"22","author":"Josephson","year":"2006","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijcard.2006.01.048","article-title":"A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle","volume":"114","author":"Giardini","year":"2007","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.117.031544","article-title":"Systemic right ventricle in adults with congenital heart disease: anatomic and phenotypic spectrum and current approach to management","volume":"137","author":"Brida","year":"2018","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2010.08.068","article-title":"Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle","volume":"154","author":"Tutarel","year":"2012","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2010.09.057","article-title":"Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot)","volume":"154","author":"Babu-Narayan","year":"2012","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/eurheartj\/ehn215","article-title":"Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients","volume":"29","author":"Giardini","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.105.592410","article-title":"Arrhythmias in adult patients with congenital heart disease","volume":"115","author":"Walsh","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B22","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B23","first-page":"e1","article-title":"PACES\/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD)","volume":"30","author":"Khairy","year":"2014","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B24","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1586\/14779072.2013.854703","article-title":"Thrombosis in congenital heart disease","volume":"11","author":"Khairy","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B25","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.hrthm.2016.07.016","article-title":"Use of dofetilide in adult patients with atrial arrhythmias and congenital heart disease: a PACES collaborative study","volume":"13","author":"El-Assaad","year":"2016","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2017.12.038","article-title":"Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: implementation of guidelines","volume":"257","author":"Yang","year":"2018","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10557-017-6745-y","article-title":"Is initiating NOACs for atrial arrhythmias safe in adults with congenital heart disease?","volume":"31","author":"Yang","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0735-1097(98)00187-9","article-title":"A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects","volume":"32","author":"Silka","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.105.548727","article-title":"Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome","volume":"113","author":"Babu-Narayan","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B30","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B31","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B32","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1016\/j.ijcard.2013.06.058","article-title":"Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation","volume":"168","author":"Potter","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B33","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","article-title":"Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association","volume":"128","author":"Giglia","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjcard.2015.10.062","article-title":"Usefulness of direct oral anticoagulants in adult congenital heart disease","volume":"117","author":"Pujol","year":"2016","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/eurheartj\/ehv743","article-title":"Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects","volume":"37","author":"Diller","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B39","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx493.P5462","article-title":"P5462: evaluation of macitentan in patients with Eisenmenger syndrome: results from the randomised controlled MAESTRO study","volume":"38","author":"Galie","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B40","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B41","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B42","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0000000000000727","article-title":"Selexipag in congenital heart disease-associated pulmonary arterial hypertension and Eisenmenger syndrome: first report","author":"El-Kersh","year":"2018","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2010.10.051","article-title":"Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology","volume":"155","author":"D'Alto","year":"2012","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B44","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijcard.2014.09.024","article-title":"Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions","volume":"177","author":"Gatzoulis","year":"2014","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2010.05.066","article-title":"Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and\/or the Eisenmenger syndrome","volume":"151","author":"Tay","year":"2011","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B46","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2017-312106","article-title":"Pulmonary arterial hypertension in adult congenital heart disease","author":"Brida","year":"2018","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B47","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/ehx034","article-title":"Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease","volume":"38","author":"van der Feen","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B49","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040104595778900_ehy480-B50","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1161\/CIR.0000000000000458","article-title":"Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association","volume":"135","author":"Canobbio","year":"2017","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/13\/1049\/28246902\/ehy480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T05:00:48Z","timestamp":1554094848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/13\/1049\/5077321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":50,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2018,8,21]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy480","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2018,8,21]]}}}